Christopher Cowles, Ph.D.

External publications

• 'In Amgen-Sanofi Decision, High Court Sticks to Patent Law Script,' Bloomberg Law - May 19, 2023, quoted

• 'U.S.: High Court Affirms Federal Circuit's Narrow Enablement Approach,' IP Law Daily - May 18, 2023, quoted

• 'Justices Clamp Down on Broad Patents in Amgen Decision,' Law360 - May 18, 2023, quoted

• 'Amgen v Sanofi: Scotus Grapples with Enablement,' Life Sciences IP Review - March 28, 2023, featured

• 'Withers Launches Venture Capital and Life Sciences Team in Boston,' Intellectual Property Magazine - April 20, 2021, featured

• 'News Digest: On the Move,' World Trademark Review, April 20, 2021, featured

• Contributing author, The Evolution of Patent Ineligible Subject Matter and the Federal Circuit, Journal of the Federal Circuit Historical Society, Vol.9, 2015

• "More PTAB Fights Between Big Pharma Could Be Looming," Intellectual Property Law360, July 2017, quoted

• More PTAB Fights Between Big Pharma Could Be Looming, July 19, 2017, featured

• Burns & Levinson Expands IP Practice with Eye on the Life Sciences, July 7, 2017, featured

• People on the move in R.I., June 2, 2017, featured